Evidence map›Paper›PMID 30021820›Full record

ArticleJournal of clinical microbiology2018

Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.

Mansoureh Vatanshenassan, Teun Boekhout, Cornelia Lass-Flörl, Michaela Lackner, Sören Schubert, Markus Kostrzewa, Katrin Sparbier

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. [Rapid detection of fluconazole resistance inNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  2. Article
  3. Journal of fungi (Basel, Switzerland) · 2026
    Review
  4. Detection of Fluconazole Resistance inJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. [Research advances on invasive fungal infections after burns].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Studies in mycology · 2021
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Mansoureh VatanshenassanBruker Daltonik GmbH, Bremen, Germany.
Teun BoekhoutInstitute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands.
Cornelia Lass-FlörlDivision of Hygiene and Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Michaela LacknerDivision of Hygiene and Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Sören SchubertMax von Pettenkofer-Institut, Munich, Germany.
Markus KostrzewaBruker Daltonik GmbH, Bremen, Germany Markus.Kostrzewa@bruker.com Katrin.Sparbier@bruker.com.
Katrin SparbierBruker Daltonik GmbH, Bremen, Germany Markus.Kostrzewa@bruker.com Katrin.Sparbier@bruker.com.
Bruker (Germany) · DEUniversity of Amsterdam · NLInnsbruck Medical University · ATUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of candidemia caused by

Indexed as

Drug Resistance, FungalSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntifungal AgentsCandidaCandida albicansCandida glabrataCandidemiaCaspofunginDiagnostic Tests, RoutineHumansMicrobial Sensitivity TestsReproducibility of ResultsSensitivity and SpecificityTime FactorsAntifungal AgentsCaspofunginantifungal susceptibility testingCandida spp.MALDI-TOF MS

Identifiers

PMID30021820
PMCPMC6113492
OpenAlexW2883894932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.